Testing & Verification
Every SEQUENCE batch is submitted for third-party analytical testing through Janoshik, a trusted independent laboratory recognized throughout the peptide and research compound space.
Each Certificate of Analysis provides batch-specific verification, helping confirm the identity, purity, and analytical profile of the product before it is made available through SEQUENCE.
No vague claims. No blind trust. Just batch-level transparency.
Every SEQUENCE batch is submitted for third-party analytical testing before being listed for sale.
In a market where labels are easy to print and harder to prove, batch-level testing gives customers a clearer way to verify what they are purchasing. Each result is tied to a specific compound, batch number, purity percentage, and method of analysis.
This is about making the paperwork visible.
SEQUENCE testing is focused on confirming key quality markers for each batch, including compound identity and analytical purity.
Each Certificate of Analysis may include:
Compound identification – confirming the tested material matches the listed compound.
Purity percentage – showing the reported analytical purity of the tested sample.
Method of analysis – identifying the testing method used, such as HPLC-UV.
Batch reference – connecting the test result to a specific SEQUENCE batch number.
The goal is simple: the vial, the batch, and the report should all line up.
SEQUENCE works with Janoshik, a third-party analytical testing provider used throughout the peptide and research compound space.
Independent testing adds a layer of verification beyond supplier paperwork, internal documentation, or generic product claims.
A supplier claim is not the same thing as a batch-specific analytical result.
That difference matters.
Purity percentage reflects the analytical purity of the tested sample based on the method used by the laboratory.
A high purity percentage is important, but it should not be viewed in isolation. Product integrity also depends on proper sourcing, labeling accuracy, storage, batch traceability, and fulfillment discipline.
SEQUENCE displays purity results clearly so customers can review the data directly instead of relying on vague claims.
The number matters.
The context matters too.
Each SEQUENCE product batch is assigned a batch number that connects the physical product to its available testing documentation.
This helps customers search, review, and verify the corresponding Certificate of Analysis for the product they are receiving.
Batch traceability helps reduce confusion between different production runs and gives each result a clear reference point.
No mystery batches.
No floating paperwork.
No “close enough.”
Certificates of Analysis are provided for transparency and batch-level verification purposes only.
Results apply to the specific batch tested and may not represent previous or future batches of the same compound. Testing results should not be interpreted as medical guidance, dosage instruction, therapeutic approval, or a guarantee of suitability for any individual use.
SEQUENCE products should be handled and used only in accordance with all applicable laws, product classifications, and customer responsibilities within the relevant jurisdiction.
Lab Result: BPC-157 10mg
Avg. Purity: 99.015%
Avg. Mass: 10.46 mg
Type of Analysis: HPLC-UV
Batch Number: SQ-0426
Testing Ordered: August 19, 2026
Sample Received: August 26, 2026
Lab Result: GHK-Cu 50mg
Avg. Purity: 99.693%
Avg. Mass: 53.06 mg
Type of Analysis: HPLC-UV
Batch Number: SQ-0432
Testing Ordered: August 19, 2026
Sample Received: August 26, 2026
Lab Result: Kisspeptin 10mg
Avg. Purity: 98.976%
Avg. Mass: 10.27 mg
Type of Analysis: HPLC-UV
Batch Number: SQ-0419
Testing Ordered: August 19, 2026
Sample Received: August 26, 2026
Lab Result: Epithalon (Epitalon) 10mg
Avg. Purity: 99.732%
Avg. Mass: 10.33 mg
Type of Analysis: HPLC-UV
Batch Number: SQ-0420
Testing Ordered: August 19, 2026
Sample Received: August 26, 2026
Lab Result: MOTS-c 10mg
Avg. Purity: 99.002%
Avg. Mass: 10.59 mg
Type of Analysis: HPLC-UV
Batch Number: SQ-421
Testing Ordered: August 19, 2026
Sample Received: August 26, 2026
Lab Result: Selank 10mg
Avg. Purity: 98.975%
Avg. Mass: 10.19 mg
Type of Analysis: HPLC-UV
Batch Number: SQ-422
Testing Ordered: August 19, 2026
Sample Received: August 26, 2026
Lab Result: Semax 10mg
Avg. Purity: 99.832%
Avg. Mass: 10.11 mg
Type of Analysis: HPLC-UV
Batch Number: SQ-423
Testing Ordered: August 19, 2026
Sample Received: August 26, 2026
Lab Result: NAD+ 500mg
Avg. Purity: 99.879%
Avg. Mass: 508.96 mg
Type of Analysis: HPLC-UV
Batch Number: SQ-424
Testing Ordered: August 19, 2026
Sample Received: August 26, 2026
